YI 2.6 Comparison of Cardiovascular Disease Primary Prevention Guidelines between Australia, England and the United States

DOI

10.2991/artres.k.201209.014How to use a DOI?

Keywords

Lipid; hypertension; obesity

Abstract

Objective: Cardiovascular disease (CVD) primary prevention guidelines recommend absolute CVD risk estimation to guide blood pressure and lipid therapy recommendations but are inconsistent despite relying on similar evidence. This study aimed to compare the populations recommended for treatment according to guidelines in Australia, England and the United States.

Methods: Cross-sectional analysis of national health survey data from Australian, English and United States (n = 4,056; n = 2,994; n = 2,943; respectively) adults aged ≥40 years. Participants were classified as recommended for therapy based on clinical characteristics denoting high risk and absolute CVD risk stratification according to each country’s guidelines [1–6]. Agreement in therapy recommendation assessed by Kappa statistic.

Results: Agreement in therapy recommendation was minimal to weak (κ = 0.35–0.54). Proportions recommended for either blood pressure or lipid lowering treatment ranged between 26–32%, 47–52% and 43–47% in Australia, England and United States. There was minimal to strong agreement in therapy recommendation according to clinical criteria (κ = 0.38–0.83) and minimal to moderate agreement according to absolute CVD risk (κ = 0.28–0.64) across guidelines.

Conclusion: Despite similar evidence apparently underpinning guidance, there is little agreement in the populations targeted for CVD primary prevention with Australia recommending far few people for treatment in comparison to England or the United States. This is due to differences in both clinical characteristics considered high risk and absolute CVD risk stratification. Whilst different countries may adopt different policies on the appropriate level of risk to target, these findings suggest a need to develop international consensus definition for high CVD risk in primary prevention guideline

Copyright

© 2020 Association for Research into Arterial Structure and Physiology. Publishing services by Atlantis Press International B.V.

Open Access

This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)
View full text (HTML)

TY  - JOUR
AU  - Niamh Chapman
AU  - Monique Breslin
AU  - Sarah Lay-Flurrie
AU  - Zhen Zhou
AU  - James Sharman
AU  - Mark Nelson
AU  - Richard McManus
PY  - 2020
DA  - 2020/12/31
TI  - YI 2.6 Comparison of Cardiovascular Disease Primary Prevention Guidelines between Australia, England and the United States
JO  - Artery Research
SP  - S19
EP  - S19
VL  - 26
IS  - Supplement 1
SN  - 1876-4401
UR  - https://doi.org/10.2991/artres.k.201209.014
DO  - 10.2991/artres.k.201209.014
ID  - Chapman2020
ER  -